Review of nintedanib plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial
about
Review of nintedanib plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Review of nintedanib plus peme ...... ebo-controlled LUME-Meso trial
@en
Review of nintedanib plus peme ...... ebo-controlled LUME-Meso trial
@nl
type
label
Review of nintedanib plus peme ...... ebo-controlled LUME-Meso trial
@en
Review of nintedanib plus peme ...... ebo-controlled LUME-Meso trial
@nl
prefLabel
Review of nintedanib plus peme ...... ebo-controlled LUME-Meso trial
@en
Review of nintedanib plus peme ...... ebo-controlled LUME-Meso trial
@nl
P2860
P356
P1476
Review of nintedanib plus peme ...... ebo-controlled LUME-Meso trial
@en
P2093
P2860
P304
S3124-S3127
P356
10.21037/JTD.2018.07.105
P407
P433
P577
2018-09-01T00:00:00Z